80:oral Is there something special about rare diseases? Examining societal preferences for exempting orphan drugs from cost-effectiveness criteria for reimbursement

• Werner Brouwer,
• Lucas Goossens,
• Vivian Reckers-Droog,
• Job van Exel

Affiliations

Werner Brouwer

Research fellow.

Lucas Goossens

Erasmus School of Health Policy & Management, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands

Vivian Reckers-Droog

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands

Job van Exel

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands